Moderna COVID-19 vaccine 100% effective in adolescents, company says
Fox News
Moderna’s COVID-19 vaccine was 100% effective in adolescents aged 12 to 17 in a clinical trial, the company announced Tuesday.
"We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents. It is particularly exciting to see that the Moderna COVID-19 vaccine can prevent SARS-CoV-2 infection," said Stéphane Bancel, CEO of Moderna, in a statement posted Tuesday. "We will submit these results to the U.S. FDA and regulators globally in early June and request authorization. We remain committed to doing our part to help end the COVID-19 pandemic."More Related News